BUB
NVO

BBVA USA Bancshares’s Novo Nordisk NVO Stock Holding History

BBVA USA Bancshares’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$3.73M Sell
110,564
-1,252
-1% -$44.6K 0.18% 129
2020
Q4 		$3.9M Sell
111,816
-17,770
-14% -$614K 0.2% 116
2020
Q3 		$4.49M Sell
129,586
-35,032
-21% -$1.17M 0.26% 95
2020
Q2 		$5.39M Sell
164,618
-69,390
-30% -$2.21M 0.32% 78
2020
Q1 		$7.04M Sell
234,008
-9,514
-4% -$283K 0.5% 50
2019
Q4 		$7.05M Sell
243,522
-2,948
-1% -$81.6K 0.4% 59
2019
Q3 		$6.37M Sell
246,470
-16,994
-6% -$430K 0.41% 62
2019
Q2 		$6.72M Sell
263,464
-1,464
-0.6% -$36.2K 0.41% 58
2019
Q1 		$6.93M Buy
264,928
+7,702
+3% +$189K 0.44% 55
2018
Q4 		$5.92M Sell
257,226
-20,482
-7% -$455K 0.42% 58
2018
Q3 		$6.54M Sell
277,708
-1,758
-0.6% -$42.9K 0.39% 65
2018
Q2 		$6.44M Sell
279,466
-1,936
-0.7% -$46K 0.41% 60
2018
Q1 		$6.93M Buy
281,402
+1,364
+0.5% +$35.8K 0.45% 54
2017
Q4 		$7.51M Buy
280,038
+9,264
+3% +$236K 0.48% 48
2017
Q3 		$6.52M Buy
270,774
+12,414
+5% +$281K 0.43% 58
2017
Q2 		$5.54M Buy
258,360
+32,292
+14% +$652K 0.36% 70
2017
Q1 		$3.88M Buy
226,068
+13,316
+6% +$232K 0.26% 95
2016
Q4 		$3.81M Sell
212,752
-30,212
-12% -$548K 0.27% 90
2016
Q3 		$5.05M Sell
242,964
-4,506
-2% -$112K 0.37% 73
2016
Q2 		$6.66M Sell
247,470
-2,172
-0.9% -$59.6K 0.5% 50
2016
Q1 		$6.76M Buy
249,642
+29,056
+13% +$778K 0.51% 48
2015
Q4 		$6.41M Buy
220,586
+15,634
+8% +$433K 0.48% 54
2015
Q3 		$5.56M Buy
204,952
+26,696
+15% +$756K 0.43% 61
2015
Q2 		$4.88M Buy
178,256
+39,538
+29% +$1.11M 0.27% 101
2015
Q1 		$3.7M Buy
138,718
+44,344
+47% +$1.02M 0.17% 159
2014
Q4 		$2M Buy
94,374
+27,990
+42% +$625K 0.09% 195
2014
Q3 		$1.58M Buy
+66,384
New +$1.53M 0.07% 211

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBVA USA Bancshares's NVO Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Novo Nordisk (NVO) stake by 1.1% in Q1 2021, selling an estimated $44.6K and leaving 110,564 shares worth $3.73M. The position accounts for 0.18% of the portfolio, ranked #129.

BBVA USA Bancshares first reported a position in NVO in Q3 2014 and has held it in 27 quarters since. The position peaked at $7.51M in Q4 2017. 708 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

  • BBVA USA Bancshares held 110,564 shares of Novo Nordisk worth $3.73M as of Q1 2021.
  • BBVA USA Bancshares sold 1,252 Novo Nordisk shares in Q1 2021, an estimated $44.6K.
  • Novo Nordisk made up 0.18% of BBVA USA Bancshares's portfolio in Q1 2021, its #129 holding.
  • BBVA USA Bancshares first reported a position in Novo Nordisk in Q3 2014 and has held it in 27 quarters since.
  • BBVA USA Bancshares's Novo Nordisk position peaked at $7.51M in Q4 2017.
  • 708 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.